Related Experiment Videos
Selective visual attention in Alzheimer's and Parkinson's patients: memory- and data-driven control
F M Cossa1, S Della Sala, H Spinnler
1Neuropsychology Laboratory, Clinica del Lavoro Foundation, Institute of Care and Research, Novara, Italy.
Neuropsychologia
|January 1, 1989
Summary
Patients with incipient Alzheimer's disease showed impaired selective attention control, unlike Parkinson's patients and healthy controls. Alzheimer's patients struggled with stimulus context and accuracy, suggesting reduced attentional resources.
Area of Science:
- Cognitive Psychology
- Neuroscience
- Clinical Neurology
Background:
- Selective attention is crucial for cognitive function.
- The Norman and Bobrow (1975) model explains attentional resource allocation and speed-accuracy trade-offs.
- Incipient Alzheimer's disease (AD) and Parkinson's disease (PD) affect cognitive processes, including attention.
Purpose of the Study:
- To investigate selective attention control in incipient Alzheimer's disease.
- To compare attentional performance in Alzheimer's patients, non-demented Parkinsonians, and healthy controls.
- To evaluate the applicability of the Norman and Bobrow (1975) model to these patient groups.
Main Methods:
- An automated visual search experiment was employed.
- Participants included patients with incipient Alzheimer's disease, non-demented Parkinsonians, and healthy controls.
- Performance metrics assessed selective attention and speed-accuracy trade-offs.
Main Results:
- Healthy controls and Parkinson's patients' performance aligned with the Norman and Bobrow model.
- Alzheimer's patients demonstrated significant deviations from the model's predictions.
- Alzheimer's patients showed reduced sensitivity to stimulus context facilitation and prioritized accuracy over speed.
Conclusions:
- Incipient Alzheimer's disease disrupts selective attention control.
- Reduced attentional resources in Alzheimer's patients may impair the speed-accuracy trade-off mechanism.
- The Norman and Bobrow model effectively differentiates attentional deficits in neurodegenerative diseases.